Synergy CHC Corp. Revenue
Synergy CHC Corp. (SNYR) reported Revenue of $5.49 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-14.
Financial Statements › Income Statement
us-gaap:Revenues · last filed 2026-05-14
- Synergy CHC Corp. revenues for the quarter ending 2026-03-31 was $5.49M, a 32.77% decline year-over-year.
- Synergy CHC Corp. revenues for the quarter ending 2025-12-31 was $6.07M, a 40.95% decline year-over-year.
- Synergy CHC Corp. revenues for the quarter ending 2025-09-30 was $8.01M, a 12.40% increase year-over-year.
- Synergy CHC Corp. revenues for the quarter ending 2025-06-30 was $8.13M, a 1.37% increase year-over-year.
- Synergy CHC Corp. revenues for fiscal 2025 was $30.38M, a 12.78% decline from fiscal 2024.
- Synergy CHC Corp. revenues for fiscal 2024 was $34.83M, a 18.57% decline from fiscal 2023.
- Synergy CHC Corp. revenues for fiscal 2023 was $42.78M.
- Synergy CHC Corp. revenues for fiscal 2018 was $33.82M, a 4.98% decline from fiscal 2017.
| Period end | Revenues 3 month | Revenues 6 month | Revenues 9 month | Revenues 12 month |
|---|---|---|---|---|
| 2026-03-31 | $5.49M 10-Q · filed 2026-05-14 | $11.56M derived: sum of 2 quarters · filed 2026-05-14 | $19.57M derived: sum of 3 quarters · filed 2026-05-14 | $27.70M derived: sum of 4 quarters · filed 2026-05-14 |
| 2025-12-31 | $6.07M derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-01 | $14.08M derived: sum of 2 quarters · filed 2026-04-01 | $22.21M derived: sum of 3 quarters · filed 2026-04-01 | $30.38M 10-K · filed 2026-04-01 |
| 2025-09-30 | $8.01M 10-Q · filed 2025-11-13 | $16.15M derived: sum of 2 quarters · filed 2025-11-13 | $24.32M 10-Q · filed 2025-11-13 | $34.59M derived: sum of 4 quarters · filed 2026-05-14 |
| 2025-06-30 | $8.13M 10-Q · filed 2025-08-14 | $16.31M 10-Q · filed 2025-08-14 | $26.58M derived: sum of 3 quarters · filed 2026-05-14 | $33.70M derived: sum of 4 quarters · filed 2026-05-14 |
| 2025-03-31 | $8.17M 10-Q · filed 2026-05-14 | $18.44M derived: sum of 2 quarters · filed 2026-05-14 | $25.57M derived: sum of 3 quarters · filed 2026-05-14 | $33.59M derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | $10.27M derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-01 | $17.40M derived: sum of 2 quarters · filed 2026-04-01 | $25.42M derived: sum of 3 quarters · filed 2026-04-01 | $34.83M 10-K · filed 2026-04-01 |
| 2024-09-30 | $7.13M 10-Q · filed 2025-11-13 | $15.15M derived: sum of 2 quarters · filed 2025-11-13 | $24.56M 10-Q · filed 2025-11-13 | $37.78M derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | $8.02M 10-Q · filed 2025-08-14 | $17.44M 10-Q · filed 2025-08-14 | $30.65M derived: sum of 3 quarters · filed 2025-08-14 | $41.46M derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | $9.41M 10-Q · filed 2025-05-15 | $22.63M derived: sum of 2 quarters · filed 2025-05-15 | $33.44M derived: sum of 3 quarters · filed 2025-05-15 | |
| 2023-12-31 | $13.22M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $24.02M derived: sum of 2 quarters · filed 2025-03-31 | $42.78M 10-K · filed 2025-03-31 | |
| 2023-09-30 | $10.81M 10-Q · filed 2024-12-06 | $29.56M 10-Q · filed 2024-12-06 | ||
| 2018-12-31 | $5.20M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-29 | $14.39M derived: sum of 2 quarters · filed 2019-03-29 | $24.12M derived: sum of 3 quarters · filed 2019-03-29 | $33.82M 10-K · filed 2019-03-29 |
| 2018-09-30 | $9.19M 10-Q · filed 2018-11-13 | $18.92M derived: sum of 2 quarters · filed 2018-11-13 | $28.62M 10-Q · filed 2018-11-13 | $34.93M derived: sum of 4 quarters · filed 2019-03-29 |
| 2018-06-30 | $9.73M 10-Q · filed 2018-08-14 | $19.43M 10-Q · filed 2018-08-14 | $25.74M derived: sum of 3 quarters · filed 2019-03-29 | $34.92M derived: sum of 4 quarters · filed 2019-03-29 |
| 2018-03-31 | $9.70M 10-Q · filed 2018-05-15 | $16.01M derived: sum of 2 quarters · filed 2019-03-29 | $25.19M derived: sum of 3 quarters · filed 2019-03-29 | $34.51M derived: sum of 4 quarters · filed 2019-03-29 |
| 2017-12-31 | $6.31M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-29 | $15.49M derived: sum of 2 quarters · filed 2019-03-29 | $24.81M derived: sum of 3 quarters · filed 2019-03-29 | $35.60M 10-K · filed 2019-03-29 |
| 2017-09-30 | $9.18M 10-Q · filed 2018-11-13 | $18.49M derived: sum of 2 quarters · filed 2018-11-13 | $29.28M 10-Q · filed 2018-11-13 | $36.01M derived: sum of 4 quarters · filed 2018-11-13 |
| 2017-06-30 | $9.32M 10-Q · filed 2018-08-14 | $20.11M 10-Q · filed 2018-08-14 | $26.84M derived: sum of 3 quarters · filed 2018-08-14 | $38.41M derived: sum of 4 quarters · filed 2018-08-14 |
| 2017-03-31 | $10.79M 10-Q · filed 2018-05-15 | $17.52M derived: sum of 2 quarters · filed 2018-05-15 | $29.09M derived: sum of 3 quarters · filed 2018-05-15 | $37.36M derived: sum of 4 quarters · filed 2018-05-15 |
| 2016-12-31 | $6.73M derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02 | $18.30M derived: sum of 2 quarters · filed 2018-04-02 | $26.57M derived: sum of 3 quarters · filed 2018-04-02 | $34.84M 10-K · filed 2018-04-02 |
| 2016-09-30 | $11.57M 10-Q · filed 2017-11-13 | $19.84M derived: sum of 2 quarters · filed 2017-11-13 | $28.11M 10-Q · filed 2017-11-13 | $34.33M derived: sum of 4 quarters · filed 2017-11-13 |
| 2016-06-30 | $8.27M 10-Q · filed 2017-08-14 | $16.54M 10-Q · filed 2017-08-14 | $22.76M derived: sum of 3 quarters · filed 2017-08-14 | $25.94M derived: sum of 4 quarters · filed 2017-08-14 |
| 2016-03-31 | $8.27M 10-Q · filed 2017-05-01 | $14.49M derived: sum of 2 quarters · filed 2017-05-01 | $17.67M derived: sum of 3 quarters · filed 2017-05-01 | $20.12M derived: sum of 4 quarters · filed 2017-05-01 |
| 2015-12-31 | $6.22M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-24 | $9.40M derived: sum of 2 quarters · filed 2017-03-24 | $11.86M derived: sum of 3 quarters · filed 2017-03-24 | $13.46M 10-K · filed 2017-03-24 |
| 2015-09-30 | $3.18M 10-Q · filed 2016-10-26 | $5.64M derived: sum of 2 quarters · filed 2016-10-26 | $7.24M 10-Q · filed 2016-10-26 | $7.24M derived: sum of 4 quarters · filed 2016-10-26 |
| 2015-06-30 | $2.46M 10-Q · filed 2016-08-05 | $4.06M 10-Q · filed 2016-08-05 | $4.06M derived: sum of 3 quarters · filed 2016-08-05 | $4.06M derived: sum of 4 quarters · filed 2016-08-05 |
| 2015-03-31 | $1.60M 10-Q · filed 2016-04-25 | $1.61M derived: sum of 2 quarters · filed 2016-04-25 | $1.61M derived: sum of 3 quarters · filed 2016-04-25 | $1.61M derived: sum of 4 quarters · filed 2016-04-25 |
| 2014-12-31 | $6.41K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | $6.41K derived: sum of 2 quarters · filed 2016-03-30 | $9.16K derived: sum of 3 quarters · filed 2016-03-30 | $9.16K 10-K · filed 2016-03-30 |
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-16 | $2.75K derived: sum of 2 quarters · filed 2015-11-16 | $2.75K 10-Q · filed 2015-11-16 | |
| 2014-06-30 | $2.75K 10-Q · filed 2015-08-13 | $2.75K 10-Q · filed 2015-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |